PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the Netherlands
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.499
https://www.valueinhealthjournal.com/article/S1098-3015(11)02061-4/fulltext
Title :
PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02061-4&doi=10.1016/j.jval.2011.08.499
First page :
A323
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
473